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The autologous mixed lymphocyte reaction (AMLR),' is the proliferative
response ofT lymphocytes cultured with autologous non-T cells (1, 2) . T cells,
activated in the human AMLR, exhibit both immunological memory and speci-
ficity (3) . The interaction of T lymphocytes with autologous or syngeneic cells
in vitro results in the expression of helper, suppressor, and cytotoxic activity, as
well as in the secretion of immunoregulatory soluble factors (reviewed in refer-
ences 4 and 5) .
T cells activated by autologous macrophages participate in the immune re-
sponse to antigen (6, 7) . The activation of T cells in the syngeneic mixed
lymphocyte reaction (SMLR) is governed by the same genetic rules that regulate
antigen-specific T cells (8-10) . Finally, the SMLR is compromised in autoim-
mune-prone strains of mice, BXSB, MRL, and NZB, as is the AMLR in humans
with diseases associated with immunological abnormalities such as systemic lupus
erythematosus, Sjogren's syndrome, infectious mononucleosis, and rheumatoid
arthritis (4, 11-13) . These data suggest the possibility that autoreactive T cells
may be important regulatory elements in the normal immune response .
While a monoclonal antibody to a subpopulation of autoreactive T cells has
been developed for human cells, this antibody did not permit a direct assessment
of the biological significance of the autologous mixed lymphocyte reaction (14) .
For this reason we developed antibodies specific for autoreactive T cells in the
mouse with the purpose of defining the relevance of the SMLR by direct in vivo
manipulations . These monoclonal antibodies blocked the SMLR but did not
affect the allogeneic MLR or the proliferative response of T cells to phytohe-
magglutinin (PHA) . Similarly, splenic T cells from mice treated with these
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antibodies were impaired in their capacity to proliferate in an SMLR, but had
normal responses to allogeneic spleen cells and to PHA .
Materials and Methods
Animals.
￿
2-mo-old BALB/c and C57B1/6 male mice were obtained from Charles River
Laboratories, Inc., Wilmington, MA .
LVmphoc_yte Preparation. Mice were sacrificed by cervical dislocation. Spleens were
removed aseptically and teased apart in RPMI 1630 (Gibco Laboratories, Grand Island,
NY). Single-cell suspensions were prepared by filtration through cotton gauze . Cells were
collected by centrifugation and treated with 0.83% ammonium chloride-0.17 M Tris
buffer, pH 7.2 to lyse erythrocytes. The cells were washed twice with RPMI 1630,
resuspended, counted, and divided into stimulating and responding cell populations.
Purified responding T cell populations were prepared as described by Julius et al. (15).
Briefly, nylon wool columns were prepared and washed with RPMI 1640 (Flow Labora-
tories, Inc., McLean, VA) supplemented with 20 mM Hepes buffer (Gibco Laboratories)
and 1 % fresh normal syngeneic mouse serum (NMS). The column was drained thoroughly
and equilibrated in a 37°C incubator for 45-60 min. 80-100 X 106 spleen cells in 1-2 ml
of warm media were added to the column dropwise and washed into the column with an
additional 1 ml of warm media. Columns were then incubated at 37°C for 45 min in a
5% C02/95% air humidified atmosphere . Nylon wool nonadherent (NWNA) cells were
eluted with 10-15 ml of warm media at a flow rate of one drop per second. These cells
were collected by centrifugation and adjusted to 5 X 106/ml in culture media. The culture
media consisted of RPMI 1640 supplemented with 0 .5%-1 .0% NMS, 20 mM Hepes, 2
MM t.-glutamine (Gibco Laboratories), 5 X 10-' M 2-mercaptoethanol (Eastman Organic
Chemicals, Rochester, NY), 2 .5% sodium pyruvate (Microbiological Associates, Walkers-
ville, MD), 100 U/ml penicillin (Gibco), and 100,ug/ml streptomycin (Gibco). The NWNA
cells contained 5% sIg+ cells and <2% macrophages. This preparation will be referred to
as "T cells ." Stimulating cells were prepared by resuspending irradiated (3,000 rad from
a cesium source) spleen cells at a concentration of 5 X 106/ml in the above culture media.
T-depleted populations were prepared by lysis with anti-Thy-1 .2 and complement.
Anti-Thy-1 .2 was produced by the hybridoma cell line 30-H.12 obtained from Dr. N. L.
Warner (University of New Mexico), and grown intraperitoneally in pristane-pretreated,
350 rad-irradiated, BALB/c mice. The antibody containing ascites fluid was made 50%
saturated (cold) in (NH4)2SO4. The precipitate was collected, washed, dissolved, dialyzed,
and applied to a DE-52 column, and the rate IgG2b anti-mouse Thy-1 .2 was eluted with
a Tris-phosphate buffer gradient.
Splenocytes to be treated were suspended to 10'/ml in RPMI 1640 supplemented with
5% fetal bovine serum and a 1 :400 dilution of anti-Thy-1 .2 for 45 min at 4°C. Cells were
washed twice and resuspended to 10'/ml in media containing a 1 :12 dilution of Low Tox
rabbit complement (C) (Cederlane Laboratories, Hornb~ Ontario, Canada) for 45 min at
37 ° C. The cells were washed twice, resuspended to 10 /ml in RPMI 1640 and cultured
in 100 X 15-mm Falcon petri dishes (Falcon Labware, Oxnard, CA) at 37°C for 45 min.
The nonadherent cells, referred to as °B cells," were removed by gentle pipetting. The
remaining adherent cells were removed by a 10-min exposure to a 1 :5 dilution of 2%
Xylocaine (Astra Pharmaceutical Products, Inc., Worcester, MA) in RPMI 1640. The
adherent monocytes and the B cells were washed twice and resuspended to 10'/ml in
RPMI 1640 for incubation with the monoclonal antibody and C.
Cell Culture.
￿
SMLR or allogeneic MLR cultures were performed in triplicate in 96-
well round-bottom microtiter plates (Linbro Scientific, Hamden, CT). 5 X 10' T cells
were cultured with medium alone or mixed with an equal number of irradiated syngeneic
or allogeneic spleen cells or with PHA (Burroughs-Wellcome Co., Research Triangle
Park, NC) at a concentration of 2.5 wg/ml in a total volume of 0 .2 ml/well. SMLR and
allogeneic MLR cultures were incubated for 5 d and 4 d respectively, and PHA-stimulated
cultures were incubated for 3 d in a 37°C 5% C02/95% air humidified atmosphere.
Proliferation was measured by the incorporation of methyl tritiated thymidine ([3H]Tdr)HAUSMAN ET AL.
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(specific activity, 2 Ci/mM; Amersham Corp., Arlington Heights, IL) (1 uCi/well in 1 Al)
during the last 8 h of culture. Cultures were harvested onto glass fiber paper (Reeve
Angle; Whatman, Inc., Clifton, NJ) by a multi-well automated sample harvester (Titertek,
Flow Laboratories). The glass fiber disks were placed in mini-vials with 3 ml of scintillation
fluid (Liquiscint; National Diagnostics, Parsippany, NJ) and counted in a Searle Delta 300
liquid scintillation counter. Data are given as the average of triplicate samples or as the A
cpm (cpm of T cells plus stimulators - cpm of T cells cultured alone).
Separation of Activated and Vonactivated Cells.
￿
SMLR cultures were established as
described above in 25-cm2 tissue culture flasks (Falcon Labware) containing equal numbers
of responding and stimulating cellsat 5 X 106/ml. Culture flasks were maintained at 37'C
in 5% C02/95% humidifiedair environment for varying lengths of time. The kinetics of
the SMLR cultures were observed to peak on the same day when cultured in either
microtiter plates or flasks. Cultures were separated into activated and nonactivated cells
by separation over a six step Percoll (Pharmacia Fine Chemicals, Uppsala, Sweden)
gradient as previously described (16). Lymphocytes from each interface were removed
with a pasteur pipette, washed twice with Hanks' balanced salt solution (HBSS) (Flow
Laboratories), counted, and resuspended in culture medium.
Preparation of Monolonal Antibodies.
￿
Antibodies to T cells responding in the SMLR
were prepared utilizing somatic cell hybridization as described by Kohler and Milstein
(17). SMLR-activated lymphocytes were isolated as described above and mixed with
complete Freund's adjuvant and injected into the peritoneum of male BALB/c mice. This
injection was followed by two intraperitoneal injections of activated cells in incomplete
Freund's adjuvant at weekly intervals and one intravenous injection of activated cells. 3 d
after the last injection, spleens were removed aseptically and single-cell suspensions
prepared and fused to the nonsecreting murine myeloma cell line SP 2/0-Ag14 with
polyethylene glycol (PEG 1000; J.T. Baker Chemical Co., Phillipsburg, NJ). The cells
were placed into multiwell plates and cultured initially in DME (Gibco) with 10% NCTC
109 (Microbiological Associates), 10% horse serum (Gibco), 1 mM oxalacetic acid (Sigma
Chemical Co., St. Louis, MO), 0.45 mM pyruvic acid (Gibco), and 10-2 M hypoxanthine,
5 X 10-5 M aminopterin, and 4 X 10-" M thymidine (HAT) (Sigma Chemical Co.).
Detection of lines producing antibodies and the classes of antibodies produced was
performed using an enzyme-linked immunosorbent assay (ELISA). Specificity for the
responding cells in the SMLR was initially determined by an indirect immunofluorescent
assay with fluorescenn-conjugated IgG goat anti-mouse Ig (N . L. Cappel Laboratories,
Cochranville, PA). Fluorescent lymphocytes were enumerated using a Zeiss fluorescent
microscope. Control T cell samples were incubated with fluorescent label alone. The
percent binding detected in these control populations was subtracted from the experi-
mental results and the data expressed as the net percent fluorescence. Four clones were
detected producing antibody with specificity for the responding cell in the SMLR. These
have been designated SMLR-2-1, 2-2, 2-5, and 2-6. They have since been subcloned and
have been stable in culture for over one year.
The IgM monoclonal antitrinitrophenyl (TNP) antibody B-22 was made by Dr. J .
Gibbons. Briefly, C57BL/6 mice were immunized with 10 wg TNP-Ficoll intravenously
and spleens were removed 4 d later and fused to the nonproducing X-63 Ag 8.653 cell
line. Specificity for the TNP determinant was assessed by ELISA and by a direct plaque-
forming cell response against TNP-SRBC target cells.
Purification of Monorlonal Antibodies.
￿
One antibody, SMLR-2-1, was purified by affinity
chromatography using a Sepharose 4B-coupled goat anti-mouse IgM column. Hybridoma
supernatant, concentrated three- to fivefold by ultrafiltration, was passed through the
column, and bound material eluted with 3 M MgCl2. This column did not retain any
horse serum protein. Fractions that contained antibody were pooled and dialyzed against
multiple changes of phosphate-buffered saline (PBS). The amount of protein present was
determined from the absorbance at 280 nm
In Vitro L,.se ofNlonoclonal Antibodies.
￿
The purified antibody was used in vitro in blocking
studies as wellas in complement-dependent cytotoxicity assays. For the blocking studies,
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as described above with 50 ttg/ml, 5 wg/ml, and 0 .5 Ag/ml purified monoclonal antibody
present for the entire culture period. For the cytotoxicity assays, 10' T cells in 1 ml of
RPMI 1640 buffered with 10 mM Hepes and 10 tag of antibody were incubated for 45
min at 4°C. After incubation the cells were washed twice and resuspended in 1 ml of a
1 :6 dilution of complement and incubated for an additional 60 min at 37°C. Cells were
washed three times and resuspended at 5 X 106/ml in culture media containing 0.5-1 .0%
NMS.
Treatment of Mice with Wonoclonal Antibody to Autoreactive T Cells.
￿
Two treatment
schedules were used to deplete the autoreactive T cell population in vivo. In the first,
BALB/c mice were injected intravenously with 20,ug of affinity-purified SMLR-2-1 for 5
d. Control mice received affinity-purified monoclonal anti-TNP antibody for the same
time period. In the second, BALB/c mice were injected with 0.4 cm' of threefold
concentrated SMLR-2-1 culture supernatant three times weekly for 4 wk (calculated to
be 20-25 wg/injection). Control animals received the same quantity of concentrated SP
2/0-Ag 14 supernatant. 3 d after the final injection, the animals were sacrificed and their
T cellscultured with syngeneic spleen cells, allogeneic spleen cells, or PHA.
SIVILR in the Presence of Syngeneic Sera .
￿
Recently, it has been reported that the
proliferative response observed in the human AMLR may be a major histocom-
patibility (MHC)-restricted response to xenoantigens, e.g., fetal calf serum (FCS)
or sheep erythrocytes (17). Lymphocytes are frequently exposed to these antigens
during the separation of T and non-T cells. Methods used to separate and culture
mouse lymphocytes in the SMLR also frequently used FCS. To eliminate the
possibility that the T cells activated in the SMLR had specificity for FCS, we
have routinely used fresh syngeneic NMS in place of FCS during the nylon wool
separation of T and non-T cells in culture.
The data presented in Table I demonstrate that there is no difference in the
amount of [3H]Tdr incorporated at the peak of the SMLR in the presence of
NMS or FCS. The peak proliferative response occurred on the fifth day of the
SMLR in the presence of either serum (data not shown). It should be noted that
the background response of T cells cultured alone for 5 d was lower (0 .2-2 .3 X
103 cpm) in the presence of NMS than in the presence of FCS (0.2-5.8 x 103
cpm). Unless stated otherwise, all experiments were carried out with 1 .0% NMS
as a serum supplement.
TABLE I
Proliferation in the SMLR in the Presence ofSyngeneic or Xenogeneic
Sera
Results
* 5 X 105 splenic T cells from BALB/c mice were cultured for 5 d with
medium alone or with an equal number of irradiated syngeneic spleen
cells. Culture medium was supplemented with either 1% NMS or 10%
FCS. Cultures were pulsed with [sH]Tdr for the last 8 h of culture. The
data are presented as the mean ± SEM .
$ The number of experiments is indicated in parentheses.
Syngeneic spleen Serum source
Responding cell cell Mouse (15)$ Fetal calf (4)*
cpnr x 10_s
T cells Absent 0.7 ± 0.2 1 .9 ± 1.3
T cells Present 7.9 ± 1 .8 8.5 ± 1 .1HAUSMAN ET AL.
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Separation of Activated front Alonactivated Cells on Percoll Gradients After an
SMLR. The densities of activated and nonactivated lymphocytes differ, and this
parameter was used to separate activated from resting lymphocytes. Lymphocytes
from a primary SMLR were fractionated on discontinuous Percoll gradients as
previously described (15). >90% of the cells at the 50-55% Percoll interface
were large lymphoblasts. These cells incorporated 75% (25,846 cpm) of the total
(34,168 cpm) [3H]Tdr. Cells at the 55-60% and 60-70% Percoll interfaces were
a mixture of large and small lymphocytes. The cells from these interfaces each
incorporated <15% of the [3H]Tdr incorporated by cells from the 50-55%
interface (55%/60% = 11 .7% ; 60%/70% = 11 .6%). Virtually all of the cells were
viable cells.
Production of Monoclonal Antibodies with Specificity for T Cells Activated in the
S,VILR. 4-6-wk-old male BALB/c mice were immunized and subsequently
boosted three times with activated cells (50%/55% Percoll interface) from an
SMLR. After fusion with the HAT-sensitive SP2/0-Ag 14 cell line, supernatants
from wells containing growing cell lines were tested for the presence of immu-
noglobulin by ELISA and for binding of lymphocytes by indirect immunofluo-
rescence (Table 1I) . Supernatant from four lines contained Ig. Three antibodies
were of the IgM class and one of the IgG class. Supernatant medium from one
actively growing clone (SMLR-2-3) had no detectable IgG or IgM.
The monoclonal antibodies raised to SMLR-activated T cells stained the
majority (57-81%) of BALB/c lymphoblasts from an SMLR, but only a small
percentage (6-8%) of fresh BALB/c splenic T cells (Table 11) . The reactivity of
SMLR-2-1 was tested on splenic T cell preparations from C57BL/6 and LAF,
mice . As in BALB/c, we found, in two experiments, that 6-8% of the T cells
reacted with this antibody. These fresh T cells were small lymphocytes as
determined by light microscopy. Ofparticular importance is that these antibodies
did not react with BALB/c lymphoblasts from an allogeneic MLR. Supernatant
from one actively growing clone that produced no detectable IgG or IgM (SMLR-
TABLE II
Specificity ofMonoclonal Antibodiesfor Autoactivated Cells*
Percent fluorescent cells
*Activated cells from a syngeneic or allogeneic MLR or fresh NWNA
spleen cells were separated and prepared for indirect immunofluores-
cenc:e as described in Materials and Methods. Hybridoma supernatant
(100 Al of a 1:5 dilution) was added to 10' cells in 100 jiI and incubated
for 30 min on ice followed by an additional incubation with the fluores-
cent antibody. 200 cells were counted per slide. B-22 is a monoclonal
IgM anti-TNP antibody.
Hybridoma super-
natant
Antibody
class
NWNA
spleen
cells
Autoacti-
vated
blasts
Alloacti-
vated
blasts
SMLR-2-1 IgM 6 65 7
SMLR-2-2 IGM 7 81 3
SMLR-2-3 - 1 <1 ND
SMLR-2-5 IGG 8 57 <1
SMLR-2-6 IgM 7 81 4
B-22 IgM ND <1 11312 MONOCLONAL ANTIBODY SPECIFIC FOR AUTOREACTIVE T CELLS
2-3) and B-22, an IgM antibody with specificity for the TNP determinant, did
not react with any of the cell populations tested.
The monoclonal antibody SMLR-2-1 did not react with B lymphocytes or
nionocytes. The data shown in Table III demonstrates that 7.5% of T cells
incubated with this antibody and C were killed. There was no significant killing
of B lymphocytes or monocytes.
Inhibition ofthe SiWLR by Monoclonal Antibodies.
￿
Supernatants from SMLR-2-1,
SMLR-2-6, and the anti-TNP B-22 cell lines as well as fresh hybridoma medium
were added to wells containing T lymphocytes and syngeneic spleen cells,
allogeneic spleen cells, or PHA at the initiation of culture. Supernatants from
SMLR-2-1 and SMLR-2-6 markedly inhibited the SMLR by >80% but had little
effect on the proliferative response induced by allogeneic (C57B1/6) spleen cells
or PHA (Table IV). This selectiveinhibition couldbe due to a non-Ig-suppressive
TABLE III
Specificity ofSMLR-2-1for Responder TCells
Tcells, B cells, and adherent macrophages were incubated with 10 wg of
affinity-purified monoclonal SMLR-2-l or NMS for 45 min at 4°C. The
cell populations were then washed twice and incubated for 1 h at 37°C
with a '/12 dilution Low Tox rabbit C. The viability of the recovered cells
was determined by trypan blue exclusion. The percentage of dead cells
wasdetermined by dividing the number of blue cells by the total number
of recovered cells.
TABLE IV
Effect ofHybridoma Supernatants on theSMLR
Stimulus
Supernatants from actively growing hybridoma cell lines were added to
BALB/c T cells cultured with syngeneic non-T cells, allogeneic non-T
cells, or 2.5 jug/ml PHA at a final dilution of 1:5. Proliferation was
measured at day 5 for the SMLR, on day 4 for the allogeneic on MLR,
and at day 3 for the PHA response. B-22 is an IgM anti-TNP monoclonal
antibody made in our laboratory. Data are the average of triplicate
samples.
Hybridoma supernatant Media
Spleen
Syn-
geneic
(Cpna x
cells
Allo-
geneic
10-3)
PHA
Culture media 1.6 11 .2 39.8 97.2
B-22 1.4 10.1 41.3 91 .1
SMLR-2-1 1.4 2.2 44.4 71 .1
SMLR-2-6 1.5 1.9 37 .8 72.4
Cells Treatment Dead cells
Tcells SMLR-2-1 + C 15.5
NMS + C 8.0
B cells SMLR-2-1 + C 7.1
NMS + C 9.0
Macrophages SMLR-2-1 + C 8.2
NMS + C 7.5HAUSMAN ET AL.
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material present in the supernatants. In order to eliminate this possibility, the
monoclonal antibody produced by clone SMLR-2-1 was purified on a goat anti-
mouse IgM affinity column. This purified antibody was added at the initiation
of cultures containing BALB/c T cells incubated with syngeneic spleen cells or
allogeneic (C57B1/6) spleen cells. The results presented in Table V demonstrate
that affinity-purified SMLR-2-1 antibody at a final concentration of 5 jug/ml
totally inhibits the SMLR of lymphocytes from BALB mice. In contrast, the
allogeneic ML.R and the PHA response were not altered by the presence of a
10-fold excess of this antibody. This same concentration of SMLR-2-1 also
markedly inhibited the SMLR of lymphocytes from C57BL/6 mice, without
diminishing the allogeneic MLR to BALB/c stimulators. Incorporation of
[sH]TdR by SMLR cultures was decreased from 7,000 to 1,000 cpm by the
addition of 5 ug/ml of SMLR-2-1 . In contrast, thymidine incorporation during
an allogeneic MLR increased from 16,000 to 27,000 cpm in the presence of
SMLR-2-1. It should be pointed out that the addition of SMLR-2-1 to T cells
cultured alone did not alter the background [sH]Tdr incorporation (data not
shown) . These data demonstrate that IgM antibody in thehybridoma supernatant
from the SMLR-2-1 hybridoma specifically blocks the SMLRoftwo H-2 disparate
strains.
Since the magnitude of the proliferative response induced by PHA was so
much greater than that of the SMLR, an effect of SMLR-2-1 on this reaction
might be obscured. For this reason we have measured the effect of SMLR-2-1
on the proliferative response induced by a wide range of PHA concentrations.
At the lowest concentration of PHA tested, thymidine incorporation was com-
pat-able in magnitude to that of the SMLR. The monoclonal antibody had no
effect on [3H]Tdr incorporation at any dose of PHA tested (Table VI).
TABLE V
Specific Inhibition ofthe SMLR by Affinity-purified Monoclonal
Antibody
['H]Tdrincorporation
5 X 105 T cells were incubated for 3 d with PHA (2.5 wg/ml) or 5 d with
an equal number of irradiated allogeneic or syngeneic spleen cells (SCx).
Cultures were pulsed with ['H]Tdr during the last 8 h of culture. Where
indicated, SMLR-2-1 antibody wasaddedin the amounts specified for the
entire culture period.
Stimulus Amount of SMLR-2-1 antibody
to cultures
None 0.5,ug/ml 5 pg/ml
added
50 jug/ml
CP?rr X 10-'
Exp. 1
PHA 16.1 ND 16.0 16.3
Allogeneic SCx 28.4 28 .7 28.7 29.0
Syngeneic SCx 6.9 6.8 0 .5
Exp. 2
PHA 75.5 77 .0 76 .3 74.0
Allogeneic SCx 22.6 24.2 23.1 23 .3
Syngeneic SCx 12.9 6.3 0.1 01314 MONOCLONAL ANTIBODY SPECIFIC FOR AUTOREACTIVE T CELLS
TABLE VI
Failure of SMLR-2-1 to Inhibit Mitogenicity byPHA
[ ßH]Tdr incorporation
SMLR-2-1
￿
Amount ofPHA added to culture
None
￿
0.25 tug/ml
￿
0 .5 jug/ml
￿
1 .0 kg/ml
￿
2 .5 tag/ml
rli}ra X 10- "
- 0 .3 7.3 20.0 44 .5 43.8
+ 0 .3 8 .3 23.7 68 .1 34.4
5X 10 5 T cells were incubated with four different concentrations ofPHA
for 3 d in the presence or absence of 5 ug/ml affinity-purified SMLR-2-1 .
Reactivity was determined by the incorporation of [ sH]Tdr on the third
day of culture .
TABLE V11
Deletion ofthe Autoresponsive Cell in the SMLR by Monoclonal SMLR-
2-1 and Complement
10' BALB/c T cells in 1 ml of RPMI 1640 with 5% FCS and 10 ug of
antibody were incubated for 45 min at room temperature. After incuba-
tion the cells were washed twice and resuspended in 1 ml of a 1 :6 dilution
ofcomplement and incubated for 45 min at 37'C . Cells were again washed
and resuspended in culture media at 5 X 10 6 viable cells/ml . The results
are the mean of two experiments .
Deletion of the Autoresponsive T Cell in the SMLR.
￿
In order to demonstrate that
these antibodies were inhibiting the functional capability of the responding cell
and not the stimulating cell population, we treated the responding T cell
population with the monoclonal antibody SMLR-2-1 and complement before
culture . Control populations were treated with media only or with complement
alone . In three experiments, treatment of the respondingT cell population with
affinity-purified antibody SMLR-2-1 and complement decreased the response to
syngeneic spleen cells by an average of 59% but did not alter the response to
allogeneic spleen cells or PHA (Table VII) . Treatment with complement alone
did not substantially alter the SMLR, the allogeneic MLR, or thePHA response .
In addition, treatment of stimulator spleen populations with the monoclonal
antibody andC did not alter their ability to stimulatean SMLR . T cells stimulated
with splenocytes treated with C alone incorporated a similar amount of [3H]Tdr
as T cells responding to stimulators treated with SMLR-2-1 and C before culture
(26,000 cpm vs . 22,000 cpm) . Thus, the results presented in Tables IV-VII
demonstrate that the monoclonal antibody SMLR-2-1 specifically inhibits the
SMLR by recognizing a determinant on T cells that responds in theSMLR .
In Vivo Depletion of T Cell Activated in the SMLR .
￿
We next tested the capacity
Treatment of cells Syngeneic
spleen
[ sH]Tdr incorporated
Allogeneic
spleen
PHA
cpn1 X 10-6
None 15.0 38.2 110 .1
C only 12 .1 49.5 115 .3
SMLR-2-1 + C 4.4 45.5 134.9HAUSMAN ET AL.
￿
1315
TABLE VIII
Treatment ofBALB/c Mice with Monoclonal Antibody
BALB/c mice received five daily intravenous injections of either 20 kLg
affinity-purifiedSMLR-2-1 or B-22 (protocol 1) or 0.4 cmsof supernatant
medium from the hybridoma or SP2/0 concentrated threefold and in-
jected three times weekly for 4 wk (protocol 2). Splenic T cells from
treated mice were cultured with Syngeneic or allogeneic spleen cells or
with PHA. The data in protocol 1 represents the results of two experi-
ments; the data in protocol 2 represents the results of four experiments.
of these antibodies to regulate autoreactive T cells in vivo. BALB/c mice were
treated with monoclonal antibody. The SMLR of Splenic T cells from mice that
received intravenous injections of SMLR-2-1 were inhibited between 52% and
83%. The allogeneic MLR and the PHA response were unaltered (Table VIII).
The SMLR-2-1 antibody did not significantly alter the capacity of spleen cells
to stimulate SMLR. Spleen cells from SMLR-2-1-treated mice and from control
mice stimulated comparable amounts of [3H]Tdr by control T cell populations.
A mean 87% of normal stimulatory capacity remained in three experiments.
This contrasted with the total ablation of the capacity of T cells from SMLR-2-
1-treated animals to respond to Syngeneic spleen cells.
Discussion
We have raised monoclonal antibodies to T lymphocytes from BALB/c mice
activated in the SMLR. The SMLR was carried out in culture medium that
contained fresh Syngeneic serum but no xenogeneic serum. Thus, the prolifera-
tive response in the SMLR did not depend upon exposure of lymphocytes to
known xenogeneic antigens . The human and guinea pig autologous mixed
lymphocyte reaction can also be generated in the absence of foreign serum
during the isolation or culture of the lymphocytes (9, 10, 21). Glimcher and her
associates (8) showed that the SMLR did not depend upon exposure to foreign
antigens during the maturation of T cells in vivo or during the preparation of
Stimulus in vitro Treatment
in vivo
[sH]Tdr
incorporation Inhibition
cpin x 10-s
Protocol 1
Syngeneicspleen None 37 .0 -
Syngeneic spleen B-22 33 .9 8
Syngeneic spleen SMLR-2-1 17 .8 52
Allogeneic spleen None 26.7 -
Allogeneic spleen SMLR-2-1 38.4 0
Protocol 2
Syngeneic spleen None 10.0 -
Syngeneic spleen SP2/0 9.0 10
Syngeneic spleen SMLR-2-1 1.7 83
Allogeneic spleen None 26.5 -
Allogeneic spleen SP2/0 25.4 4
Allogeneic spleen SMLR-2-1 27.1 0
PHA None 109.3 -
PHA SP2/0 102.8 6
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cells for culture orduring the culture period. Thus, it appears reasonably certain
that the SMLR does not depend upon exposure to foreign antigens.
Conversely, Tcell responses to foreign antigens in vitro appear to require the
participation ofautoreactive T cells (6, 7, 9). Elimination ofautoreactive T cells
using bromodeoxyuridine and light abrogated the primary and secondary re-
sponse ofT cells to a number ofsoluble antigens (7, 9). Furthermore, the SMLR
is capable offacilitating the proliferation of T cells to foreign determinants that
themselves are unable to stimulate the proliferation of T cells or their differen-
tiation into cytolytic T cells (19, 20). This mechanism probably explains the
increased thymidine incorporation observed when lymphocytes are exposed to
foreign antigens before or during the syngeneic or autologous MLR (18).
The monoclonal antibodies raised to BALB/c T cells activated in the SMLR
inhibited the response of T cells from BALB/c to syngeneic non-T cells, but did
not inhibit their response to allogeneic non-T cells or to PHA. Autoactivated T
cells express la and other activation antigens (22). It was therefore possible that
the monoclonal antibodies reacted with either the responding or stimulatory
cells, or both. As these antibodies do not react with alloactivated T cells, it
appeared that the antibodies are not directed at activation antigens per se. The
fact that pretreatment of the responding T cells with the monoclonal antibody
and complement as well as the finding that treatment of mice with monoclonal
antibody in vivo selectively inhibited the capacity ofsplenic Tcells to respond in
the SMLR supports the conclusion that the antibody reacts with a population of
T cells that includes autoreactive Tcells.
The monoclonal antibodies react with a cell surface determinant on a small
percentage (6-9%) of splenic T cells from H-2 disparate strains and isolated
alloactivated lymphoblasts. They do not react with cells required to stimulate an
SMLR. In contrast, 50-80% of isolated autoactivated lymphoblasts react with
theseantibodies. This suggests that this antibody does not react with an activation
antigen, an MHC-restricted determinant or its receptor on T cells.
Autoreactive T cells are increased in animals immunized with protein antigens
(23-25). Some antigen-induced T cells can be activated in the absence ofantigen
by self-la determinants, although their response is augmented in the presence of
nominal antigen (23, 24). It is possible that these cells proliferate in the SMLR.
Thus, those cells induced during an immune response may function in a nonspe-
cific manner, as they can be restimulated by autologous accessory cells in the
absence of nominal antigen. Recently, Zauderer and his colleagues (25) have
recovered autoreactive clones from mice immunized with protein antigens in
vivoafter restimulation with syngeneic accessory cells invitro. These cellsexpress
nonspecific helper activity, facilitating proliferation of antigen-specific B cells
and their secretion of specific antibody. Autoreactive T cells were not found
before immunization .
Immunization may stimulate T cells with a range of affinity for self-la deter-
minants. Some T cells may have low affinity receptors for syngeneic self-la
determinants and be totally dependent upon antigen-pulsed syngeneic accessory
cellsfor activation . Other T cells may have higher affinity for self-la determinants
and be stimulated by accessory cells alone, but are stimulated to a greater extent
by antigen-pulsed syngeneic accessory cells. Finally, there may be a populationHAUSMAN ET AL.
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of T cells activated in the normal immune response with high affinity for self-la
whose maximal response is induced by accessory cells alone. If autoreactive T
cells are essential for the development of an immune response to antigens, as
suggested by in vitro and in vivo studies, one would predict that mice depleted
of autoreactive cells by treatment with these monoclonal antibodies would have
immunological defects. We are now testing this hypothesis.
Summary
Monoclonal antibodies with specificity for autoreactive murine T cells have
been developed. These antibodies inhibit proliferative response of splenic T cells
activated by syngeneic spleen cells. These antibodies have no effect on the
proliferative response of T cells activated by allogeneic spleen cells or PHA. The
number of splenic T cells that react with these monoclonal antibodies is compa-
rable in several normal mouse strains.
Receivedfor publication 25 April 1983 wzd iii revisedform 18July 1983.
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